Ubs Group Ag T Rx Ade Health, Inc Transaction History

Ubs Group Ag

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$0.29 - $17.39 $2,167 - $129,990	7,475 Added 194.66%	11,315 $4,000
Q3 2022 Nov 10, 2022	BUY	$1.06 - $16.94 $3,672 - $58,697	3,465 Added 924.0%	3,840 $4,000
Q2 2022 Aug 10, 2022	SELL	$1.24 - $2.47 $3,344 - $6,661	-2,697 Reduced 87.79%	375 $1,000
Q1 2022 May 16, 2022	BUY	$1.76 - $2.77 $5,406 - $8,509	3,072 New	3,072 $9,000
Q4 2021 Feb 14, 2022	SELL	$2.36 - $4.94 $12,803 - $26,799	-5,425 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.66 - $7.17 $214 - $329	46 Added 0.86%	5,425 $27,000
Q2 2021 Aug 13, 2021	BUY	$3.11 - $6.67 $13,121 - $28,140	4,219 Added 363.71%	5,379 $24,000
Q1 2021 May 12, 2021	BUY	$5.21 - $7.85 $6,043 - $9,106	1,160 New	1,160 $6,000
Q3 2020 Nov 12, 2020	SELL	$4.8 - $7.96 $8,275 - $13,723	-1,724 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$5.36 - $7.94 $9,229 - $13,672	1,722 Added 86100.0%	1,724 $10,000
Q1 2020 May 01, 2020	BUY	$1.24 - $7.8 $2 - $15	2 New	2 $0

Ticker MEDS
Exchange NASDAQ
Sector Healthcare
Industry Pharmaceutical Retailers
Shares Outstandng 9,318,710
Market Cap $64.5M
Description
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 m...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.